Although previous studies have shown the ability of lipid mediators to exert anti-inflammatory and neurogenic properties in pre-clinical models of depression, these investigations mainly focussed on specific LOX-derived metabolites [24, 25], the specialised pro-resolving mediators, like resolvins, protectins and maresins [26, 27]. The gene discussed is LOX; the disease is depressive symptom measurement.